Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

The Cloud Cannot Save Alibaba Stock from the US-China Trade War

By Josh Enomoto, InvestorPlace Contributor

On paper, the cloud presents an opportunity for Alibaba to overcome the trade war, but the tensions disrupt the effectiveness of such a service.

3 Reasons Why Patience On CVS Health Stock Could Pay Off For Investors

By Josh Enomoto, InvestorPlace Contributor

Despite its lackluster performance in the markets, CVS stock has underappreciated moats in its health care business.

The 4 FANG Stocks Won’t Be Bitten By Regulation Threats

By Josh Enomoto, InvestorPlace Contributor

Regulation concerns have weighed heavily on FANG stocks but the underlying companies are too deeply embedded with their core industries.

Underappreciated CBD Market Is The Key For HEXO Stock

By Josh Enomoto, InvestorPlace Contributor

As a speculative cannabis play, HEXO stock has recently experienced volatility but patience toward its CBD potential could yield longer-term upside.

Unproven EV Market Threatens to Sink Nio Stock to Zero

By Josh Enomoto, InvestorPlace Contributor

A deeper look into the EV segment reveals that the much-hyped platform isn't quite ready for prime time. That being the case, unproven EV manufacturers like NIO face very serious risks.

Load More